James F Tessmer - Net Worth and Insider Trading
James F Tessmer Net Worth
The estimated net worth of James F Tessmer is at least $113,390 dollars as of 2024-04-29. James F Tessmer is the VP, Finance & Accounting of Lexicon Pharmaceuticals Inc and owns about 71,766 shares of Lexicon Pharmaceuticals Inc (LXRX) stock worth over $113,390. Details can be seen in James F Tessmer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James F Tessmer has not made any transactions after 2021-03-15 and currently still holds the listed stock(s).
Transaction Summary of James F Tessmer
James F Tessmer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James F Tessmer owns 1 companies in total, including Lexicon Pharmaceuticals Inc (LXRX) .
Click here to see the complete history of James F Tessmer’s form 4 insider trades.
Insider Ownership Summary of James F Tessmer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2021-03-15 | VP & Finance & Acctg |
James F Tessmer Latest Holdings Summary
James F Tessmer currently owns a total of 1 stock. James F Tessmer owns 71,766 shares of Lexicon Pharmaceuticals Inc (LXRX) as of March 15, 2021, with a value of $113,390.
Latest Holdings of James F Tessmer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2021-03-15 | 71,766 | 1.58 | 113,390 |
Holding Weightings of James F Tessmer
James F Tessmer Form 4 Trading Tracker
According to the SEC Form 4 filings, James F Tessmer has made a total of 2 transactions in Lexicon Pharmaceuticals Inc (LXRX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Lexicon Pharmaceuticals Inc is the sale of 22,912 shares on March 15, 2021, which brought James F Tessmer around $158,551.
Insider Trading History of James F Tessmer
- 1
James F Tessmer Trading Performance
GuruFocus tracks the stock performance after each of James F Tessmer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James F Tessmer is 229.17%. GuruFocus also compares James F Tessmer's trading performance to market benchmark return within the same time period. The performance of stocks bought by James F Tessmer within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James F Tessmer's insider trading performs compared to the benchmark.
Performance of James F Tessmer
Average Return
61.67%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10 | 229.17 | 157.5 | 61.67 | 74.27 | 29.37 |
| Relative Return to S&P 500(%) | 10.19 | 224.57 | 147.49 | 50.11 | 51.98 | 17.64 |
James F Tessmer Ownership Network
Ownership Network List of James F Tessmer
Ownership Network Relation of James F Tessmer
James F Tessmer Owned Company Details
What does Lexicon Pharmaceuticals Inc do?
Who are the key executives at Lexicon Pharmaceuticals Inc?
James F Tessmer is the VP & Finance & Acctg of Lexicon Pharmaceuticals Inc. Other key executives at Lexicon Pharmaceuticals Inc include director & President and CEO Lonnel Coats , director & 10 percent owner Raymond Debbane , and SVP & Chief Commercial Officer Thomas Garner .
Lexicon Pharmaceuticals Inc (LXRX) Insider Trades Summary
Over the past 18 months, James F Tessmer made no insider transaction in Lexicon Pharmaceuticals Inc (LXRX). Other recent insider transactions involving Lexicon Pharmaceuticals Inc (LXRX) include a net purchase of 170,000 shares made by Lonnel Coats , a net purchase of 22,000 shares made by Jeffrey L Wade , and a net purchase of 16,000 shares made by Wendy Mcdermott .
In summary, during the past 3 months, insiders sold 0 shares of Lexicon Pharmaceuticals Inc (LXRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexicon Pharmaceuticals Inc (LXRX) were sold and 29,183,050 shares were bought by its insiders, resulting in a net purchase of 29,183,050 shares.
Lexicon Pharmaceuticals Inc (LXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lexicon Pharmaceuticals Inc Insider Transactions
James F Tessmer Mailing Address
Above is the net worth, insider trading, and ownership report for James F Tessmer. You might contact James F Tessmer via mailing address: 8800 Technology Forest Place, The Woodlands Tx 77381.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
